Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial.

Keech A, Colquhoun D, Best J, Kirby A, Simes RJ, Hunt D, Hague W, Beller E, Arulchelvam M, Baker J, Tonkin A; LIPID Study Group.

Diabetes Care. 2003 Oct;26(10):2713-21.

PMID:
14514569
2.

Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians.

Vijan S, Hayward RA; American College of Physicians.

Ann Intern Med. 2004 Apr 20;140(8):650-8. Review.

PMID:
15096337
3.

Cumulative clinical trial data on atorvastatin for reducing cardiovascular events: the clinical impact of atorvastatin.

Bybee KA, Lee JH, O'Keefe JH.

Curr Med Res Opin. 2008 Apr;24(4):1217-29. doi: 10.1185/030079908X292001 . Epub 2008 Mar 20. Review.

PMID:
18358084
4.

A prospective study of pravastatin in the elderly at risk: new hope for older persons.

Shepherd J.

Am J Geriatr Cardiol. 2004 May-Jun;13(3 Suppl 1):17-24. Review.

PMID:
15133425
5.

Statin trials and goals of cholesterol-lowering therapy after AMI.

Pedersen TR.

Am Heart J. 1999 Aug;138(2 Pt 2):S177-82. Review.

PMID:
10426879
6.

Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials.

Corvol JC, Bouzamondo A, Sirol M, Hulot JS, Sanchez P, Lechat P.

Arch Intern Med. 2003 Mar 24;163(6):669-76. Review.

PMID:
12639199
7.

Long-term benefit of statin therapy initiated during hospitalization for an acute coronary syndrome: a systematic review of randomized trials.

Bavry AA, Mood GR, Kumbhani DJ, Borek PP, Askari AT, Bhatt DL.

Am J Cardiovasc Drugs. 2007;7(2):135-41. Review.

PMID:
17503884
8.

Lipoprotein abnormalities and their consequences for patients with type 2 diabetes.

Krentz AJ.

Diabetes Obes Metab. 2003 Nov;5 Suppl 1:S19-27. Review.

PMID:
14984018
10.

Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis.

Kanaya AM, Grady D, Barrett-Connor E.

Arch Intern Med. 2002 Aug 12-26;162(15):1737-45. Review.

PMID:
12153377
11.

Prevention of mortality from coronary heart disease with pravastatin.

Tonkin AM, Ryan EW.

Biomed Pharmacother. 1999 Oct;53(9):405-8. Review.

PMID:
10554675
12.

[Therapy and prevention of coronary heart diseases through lowering of the serum cholesterol levels; third consensus 'Cholesterol'. Consensus Working Group, CBO].

Simoons ML, Casparie AF.

Ned Tijdschr Geneeskd. 1998 Sep 19;142(38):2096-101. Review. Dutch. Erratum in: Ned Tijdschr Geneeskd 1998 Oct 3;142(40):2232.

PMID:
9856223
13.

Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials.

Hopper I, Billah B, Skiba M, Krum H.

Eur J Cardiovasc Prev Rehabil. 2011 Dec;18(6):813-23. doi: 10.1177/1741826711421687. Epub 2011 Aug 30. Review.

PMID:
21878448
14.

Statins for primary prevention of cardiovascular and cerebrovascular events in diabetic patients without established cardiovascular diseases: a meta-analysis.

Chen YH, Feng B, Chen ZW.

Exp Clin Endocrinol Diabetes. 2012 Feb;120(2):116-20. doi: 10.1055/s-0031-1297968. Epub 2011 Dec 20. Review.

PMID:
22187291
16.

The case for early statin therapy in acute coronary syndromes.

Arntz HR.

Cardiol Rev. 2002 Mar-Apr;10(2):91-6. Review.

PMID:
11895575
17.

The future of lipid-lowering therapy: the big picture.

Kastelein JJ.

Neth J Med. 2003 May;61(5 Suppl):35-9. Review.

18.

The need for tighter control of cardiovascular risk factors in diabetic patients.

Viberti G.

J Hypertens Suppl. 2003 Mar;21(1):S3-6. Review.

PMID:
12769160
19.

[Epidemiology of cardio-vascular complications of diabetes].

Grimaldi A, Heurtier A.

Diabetes Metab. 1999 Jun;25 Suppl 3:12-20. Review. French.

PMID:
10421988
20.

CHD: a major burden in type 2 diabetes.

Nesto R.

Acta Diabetol. 2001;38 Suppl 1:S3-8. Review.

PMID:
11829451

Supplemental Content

Support Center